prikaz prve stranice dokumenta Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project
Pristup korisnicima matične ustanove
Znanstveni rad - Pregledni rad
Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project
Journal of electrocardiology, 19 (2019); 30415-10417. https://doi.org/10.1016/j.jelectrocard.2019.09.001
Zabel, Markus; Schlögl, Simon; Lubinski, Andrzej; Svendsen, Jesper Hastrup; Bauer, Axel; Arbelo, Elena; Brusich, Sandro; Conen, David; Cygankiewicz, Iwona; Dommasch, Michael; Flevari, Panagiota; Galuszka, Jan; Hansen, Jim; Hasenfuß, Gerd; Hatala, Robert; Huikuri, Heikki V.; Kenttä, Tuomas; Kucejko, Tomasz; Haarmann, Helge; Harden, Markus; Iovev, Svetoslav; Kääb, Stefan; Kaliska, Gabriela; Katsimardos, Andreas; Kasprzak, Jaroslaw D.; Qavoq, Dariusz; Lüthje, Lars; Malik, Marek; Novotný, Tomáš; Pavlović, Nikola; Perge, Peter; Röver, Christian; Schmidt, Georg; Shalganov, Tchavdar; Sritharan, Rajeeva; Svetlosak, Martin; Sallo, Zoltan; Szavits-Nossan, Janko; Traykov, Vassil; Vandenberk, Bert; Velchev, Vasil; Vos, Marc A.; Willich, Stefan N.; Friede, Tim; Willems, Rik; Merkely, Béla; Sticherling, Christian Više autora...

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Zabel, M., Schlögl, S., Lubinski, A., Svendsen, J. H., Bauer, A., Arbelo, E. ... Sticherling, C. (2019). Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project. Journal of electrocardiology, 19., 30415-10417. doi: 10.1016/j.jelectrocard.2019.09.001

Zabel, Markus, et al. "Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project." Journal of electrocardiology, vol. 19, 2019, str. 30415-10417. https://doi.org/10.1016/j.jelectrocard.2019.09.001

Zabel, Markus, Simon Schlögl, Andrzej Lubinski, Jesper Hastrup Svendsen, Axel Bauer, Elena Arbelo, Sandro Brusich, et al. "Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project." Journal of electrocardiology 19 (2019): 30415-10417. https://doi.org/10.1016/j.jelectrocard.2019.09.001

Zabel, M., et al. (2019) 'Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project', Journal of electrocardiology, 19, str. 30415-10417. doi: 10.1016/j.jelectrocard.2019.09.001

Zabel M, Schlögl S, Lubinski A, Svendsen JH, Bauer A, Arbelo E, i sur.. Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project. Journal of electrocardiology [Internet]. 2019. [pristupljeno 03.12.2024.];19:30415-10417. doi: 10.1016/j.jelectrocard.2019.09.001

M. Zabel, et al., "Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project", Journal of electrocardiology, vol. 19, str. 30415-10417, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:905511. [Citirano: 03.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:905511
Podaci o radu
Naslov (engleski)Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project
AutorMarkus Zabel
AutorSimon Schlögl
AutorAndrzej Lubinski
AutorJesper Hastrup Svendsen
AutorAxel Bauer
AutorElena Arbelo
AutorSandro Brusich
AutorDavid Conen
AutorIwona Cygankiewicz
AutorMichael Dommasch
AutorPanagiota Flevari
AutorJan Galuszka
AutorJim Hansen
AutorGerd Hasenfuß
AutorRobert Hatala
AutorHeikki V. Huikuri
AutorTuomas Kenttä
AutorTomasz Kucejko
AutorHelge Haarmann
AutorMarkus Harden
AutorSvetoslav Iovev
AutorStefan Kääb
AutorGabriela Kaliska
AutorAndreas Katsimardos
AutorJaroslaw D. Kasprzak
AutorDariusz Qavoq
AutorLars Lüthje
AutorMarek Malik
AutorTomáš Novotný
AutorNikola Pavlović
AutorPeter Perge
AutorChristian Röver
AutorGeorg Schmidt
AutorTchavdar Shalganov
AutorRajeeva Sritharan
AutorMartin Svetlosak
AutorZoltan Sallo
AutorJanko Szavits-Nossan
AutorVassil Traykov
AutorBert Vandenberk
AutorVasil Velchev
AutorMarc A. Vos
AutorStefan N. Willich
AutorTim Friede
AutorRik Willems
AutorBéla Merkely
AutorChristian Sticherling
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
BACKGROUND: The clinical effectiveness of primary prevention implantable cardioverter defibrillator (ICD) therapy is under debate. It is urgently needed to better identify patients who benefit from prophylactic ICD therapy. The EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators (EU- CERT-ICD) completed in 2019 will assess this issue. SUMMARY: The EU-CERT-ICD is a prospective investigator-initiated non- randomized, controlled, multicenter observational cohort study done in 44 centers across 15 European countries. A total of 2327 patients with heart failure due to ischemic heart disease or dilated cardiomyopathy indicated for primary prophylactic ICD implantation were recruited between 2014 and 2018 (>1500 patients at first ICD implantation, >750 patients non-randomized non-ICD control group). The primary endpoint was all-cause mortality, and first appropriate shock was co- primary endpoint. At baseline, all patients underwent 12‑lead ECG and Holter-ECG analysis using multiple advanced methods for risk stratification as well as documentation of clinical characteristics and laboratory values. The EU-CERT-ICD data will provide much needed information on the survival benefit of preventive ICD therapy and expand on previous prospective risk stratification studies which showed very good applicability of clinical parameters and advanced risk stratifiers in order to define patient subgroups with above or below average ICD benefit. CONCLUSION: The EU- CERT-ICD study will provide new and current data about effectiveness of primary prophylactic ICD implantation. The study also aims for improved risk stratification and patient selection using clinical risk markers in general, and advanced ECG risk markers in particular.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaJournal of electrocardiology
Brojčani podacivol. 19, str. 30415-10417
p-ISSN0022-0736
DOIhttps://doi.org/10.1016/j.jelectrocard.2019.09.001
URN:NBNurn:nbn:hr:184:905511
Datum objave publikacije2019
URL dokumentahttp://bib.irb.hr/1031542
Vrsta resursaTekst
Prava pristupaInstitucijski pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-03-03 17:39:17